Dual STAT3/STAT5 inhibition as a novel treatment strategy in T-prolymphocytic leukemia. Dechow A, Timonen S, Ianevski A, Jiang Q, et al. Leukemia 2025 Apr 15. doi: 10.1038/s41375-025-02577.

Read + Share

Amedeo Smart

Independent Medical Education

Dechow A, Timonen S, Ianevski A, Jiang Q, et al. Dual STAT3/STAT5 inhibition as a novel treatment strategy in T-prolymphocytic leukemia. Leukemia 2025 Apr 15. doi: 10.1038/s41375-025-02577.
PMID: 40234614